PDF herunterladen
Eur J Pediatr Surg 2009; 19(4): 241-245
DOI: 10.1055/s-0029-1216389
Original Article

© Georg Thieme Verlag KG Stuttgart · New York

Evidence for Medium Chain Triglycerides in the Treatment of Primary Intestinal Lymphangiectasia

A. P. Desai1 , B. H. Guvenc2 , R. Carachi3
  • 1Department of Pediatric Surgery, King's College Hospital, London
  • 2Department of Pediatric Surgery, Anadolu Medical Center, Kocaeli, Turkey
  • 3Section of Surgical Paediatrics, University of Glasgow, Glasgow,United Kingdom
Weitere Informationen

Publikationsverlauf

received September 24, 2008

accepted after revision February 19, 2009

Publikationsdatum:
15. Mai 2009 (online)

    Lizenzen und Reprints

Abstract

Primary intestinal lymphangiectasia is an uncommon congenital anomaly. It is an intrinsic abnormality of the intestinal lymphatics system. Over the years, various treatment options such as diuretics, albumin transfusions and a medium chain triglycerides (MCT) diet as well as surgical options such as resection of isolated segments and peritoneal-venous shunts have been used. An MCT diet, which is a low fat, high protein diet, is increasingly used in the management of this anomaly.

Aim: The aim was to review the evidence for medium chain triglycerides as a therapeutic option in patients with primary intestinal lymphangiectasia.

Material and Methods: A literature search was performed and individual case details were extracted. We found 55 cases, of which 3 were from our own institute. The cases were divided in 2 groups: Group A (n=27) consisted of patients treated with MCT, and Group B (n=28) consisted patients not treated with MCT. Cases were analysed for symptomatic response to MCT as well as mortality.

Results: 17 of 27 cases (63%) treated with MCT had complete resolution of symptoms while only 10 of 28 (35.7%) patients in group B showed complete resolution. Mortality for Group A was 1 out of 27 (3.7%), while mortality in group B was 5 of 28 (17.85%) patients.

Conclusion: We conclude that, although an MCT diet is not completely curative in all cases, it does improve the symptoms of primary intestinal lymphangiectasia and reduces mortality. Hence it is a valid option in the paediatric age group.

Key words

nutrition - intestinal lymphangiectasia - medium chain triglycerides - review

References

  • 1 Warwick WJ, Holman RT, Quie PG. et al . Chylous ascites and lymphoedema.  J Dis Child. 1959;  98 317-329
    Google Scholar
  • 2 Jarnum S, Petersen VP. Protein-losing enteropathy.  Lancet. 1961;  1 417-421
    Google Scholar
  • 3 Cottom DG, London Dr, Wilson BDR. Neonatal eedema due to exudative enteropathy. Lancet. 1961;  1 327-330
  • 4 Waldmann TA, Steinfeld JL, Dutcher TF. et al . The role of the gastrointestinal system in “idiopathic hypoproteinemia”.  Gastroenterology. 1961;  41 197-200
    Google Scholar
  • 5 Waldmann TA, Schwab PJ. IgG (7 gamma globulin) metabolism in hypogammaglobulinaemia: studies in patients with defective gamma globulin synthesis, gastrointestinal protein loss, or both.  J Clin Invest. 1965;  44 1523-1533
    Google Scholar
  • 6 Browse NL, Wilson NM, Russo F. et al . Aetiology and treatment of chylous ascites.  Br J Surg. 1992;  79 1145-1150
    Google Scholar
  • 7 Fox U, Lucani G. Disorders of the intestinal lymphatic system.  Lymphology. 1993;  26 61-66
    Google Scholar
  • 8 Fonkalsrun EW. Congenital malformation of the lymphatic system.  Seminars in Pediatric Surgery. 1994;  3 62-69
    Google Scholar
  • 9 Vardy PA, Lebenthal E, Shwachman H. Intestinal lymphangiectasia: A reappraisal.  Pediatrics. 1975;  55 842-851
    Google Scholar
  • 10 Nazer HM, Abutalib H, Hugosson C. et al . Intestinal lymphangiectasia masquerading as coeliac disease.  Ann Trop Paediatr. 1991;  11 349-355
    Google Scholar
  • 11 Maya MM, Friedwald J. Intestinal lymphangiectasia: ultrasound evaluation of a case simulating appendicitis.  Abdom Imaging. 1993;  18 27-28
    Google Scholar
  • 12 Perisic VN, Kokai G. Coeliac disease and lymphangiectasia.  Arch Dis Child. 1992;  67 134-136
    Google Scholar
  • 13 Vallet HL, Holtzapple PG, Eberlein WR. et al . Noonan syndrome with intestinal lymphangiectasis.  A metabolic and anatomic study. J Pediatr. 1972;  80 269-274
    Google Scholar
  • 14 Perisic VN, Kokai G. Bleeding from duodenal lymphangiectasia.  Archives Dis Childhood. 1991;  66 153-154
    Google Scholar
  • 15 Lee WS, Boey CCM, Goh AYT. et al . Intestinal lymphangiectasia – A report of three Chinese children in Malaysia.  Singapore Med J. 1998;  39 418-41 421
    Google Scholar
  • 16 Strober W, Wochner RD, Carbone PP. et al . Intestinal lymphangiectasia: A protein-losing enteropathy with hypogammaglobulinaemia, lymphocytopenia and impaired homograft rejection.  J Clin Invest. 1967;  46 1643-1656
    Google Scholar
  • 17 O’Donnell D, Myers AM. Intestinal lymphangiectasia and protein losing enteropathy, toxic copper accumulation and hypoparathyroidism.  Aust NZ J Med. 1990;  20 167-169
    Google Scholar
  • 18 Stoelinga GBA, Van Munster PJJ, Slooff JP. Chylous Effusions into the intestine in a patient with protein-losing enteropathy.  Pediatrics. 1963;  31 1011-1018
    Google Scholar
  • 19 Mistilis SP, Skyring AP, Stephen DD. Intestinal lymphangiectasia.  Mechanism of enteric loss of plasma-protein and fat. Lancet. 1965;  1 77-79
    Google Scholar
  • 20 Waldmann TA. Protein-losing enteropathy.  Gastroenterology. 1966;  50 422-443
    Google Scholar
  • 21 Jeejeebhoy KN. Cause of hypoalbuminaemia in patients with gastrointestinal and cardiac disease.  Lancet. 1962;  1 343-348
    Google Scholar
  • 22 Browse NL, Stewart G. Lymphoedema: pathophysiology and classification.  J Cardiovasc Surg. 1985;  26 91-105
    Google Scholar
  • 23 Ores CN, Ores RO, Denning CR. et al . Hypercatabolic hypoproteinemia with lymphangiectasia of the small bowel.  Pediatrics. 1966;  69 439-448
    Google Scholar
  • 24 Heresbach D, Raoul J, Genetet N. et al . Immunological study in primary intestinal lymphangiectasia.  Digestion. 1994;  55 59-64
    Google Scholar
  • 25 Leyland FC, Fosbrooke AS, Lloyd JK. et al . Use of medium-chain triglycerides in children with malabsorption.  Arch Dis Childh. 1969;  44 170-179
    Google Scholar
  • 26 Jeffries GH, Chapman A, Sleisenger MH. Low-fat diet in intestinal lymphangiectasia.  Its effect on albumin metabolism. New Engl J Med. 1964;  270 761-766
    Google Scholar
  • 27 Mine K, Matsubayashi S, Nakai Y. et al . Intestinal lymphangiectasia markedly improved with antiplasmin therapy.  Gastroenterology. 1989;  96 1596-1599
    Google Scholar
  • 28 Takami A, Nakao S, Sugimori N. et al . Management of disseminated intra-abdominal lymphangiomatosis with protein-losing enteropathy and intestinal bleeding.  Southern Medical Journal. 1995;  88 1156-1158
    Google Scholar
  • 29 Holt PR. Dietary treatment of protein loss in intestinal lymphangiectasia.  Pediatrics. 1964;  34 629-635
    Google Scholar
  • 30 Rosen FS, Smith DH, Earle R. et al . The etiology of hypoproteinemia in a patient with chylous ascites.  Pediatrics. 1962;  30 696-706
    Google Scholar
  • 31 Levine C. Primary disorders of the lymphatic vessels – A unified concept.  J Paed Surg. 1989;  24 233-240
    Google Scholar
  • 32 Parfitt AM. Familial Neonatal hypoproteinaemia with exudative enteropathy and intestinal lymphangiectasis.  J Dis Child. 1966;  41 54-62
    Google Scholar
  • 33 Tift WL, Lloyd JK. Intestinal lymphangiectasia.  Long term results with MCT diet. Arch Dis Childh. 1975;  50 269-276
    Google Scholar
  • 34 Bereket A, Lowerheim M, Blethen SL. et al . Intestinal lymphangiectasia in a patient with autoimmune polyglandular disease type 1 and steatorrhoea.  J Clin Endocrinol Metab. 1995;  80 933-935
    Google Scholar
  • 35 Roisman I, Manny J, Fields S. et al . Intra-abdominal lymphangioma.  Br J Surg. 1989;  76 485-489
    Google Scholar
  • 36 Haddad HM, Wilkins L. Congenital abnormalities associates with gonadal aplasia.  Pediatrics. 1959;  23 885-902
    Google Scholar
  • 37 Dobbins WO. Hypo-beta-lipoparoteinemia and intestinal lymphangiectasia.  Arch Intern Med. 1968;  122 31-38
    Google Scholar
  • 38 Urioste M, Rodriguez JI, Barcia JM. et al . Persistence of Mullerian derivatives, lymphangiectasis, hepatic failure, postaxial polydactyly, renal and cranio-facial anomalies.  Am J Med Gen. 1993;  47 494-503
    Google Scholar
  • 39 Cormier-Daire V, Lyonnet S, Lehnert A. et al . Craniosynostosis and kidney malformation in a case of Hennekam Syndrome.  Am J Med Gen. 1995;  57 66-68
    Google Scholar
  • 40 Erdem G, Oran O, Kotiloglu E. et al . Intestinal lymphangiectasia in a patient with Zellweger cerebrohepatorenal syndrome.  Am J Med Gen. 1995;  58 152-154
    Google Scholar
  • 41 Weiden PL, Blaese RM, Strober W. et al . Impaired lymphocyte transformation in intestinal lymphangiectasia: evidence for at least two functionally distinct lymphocyte populations in man.  J Clin Invest. 1972;  51 1319-1325
    Google Scholar
  • 42 Murphy EA. N-Familial Lymphatic Dysplasia with Intestinal Lymphangiectasia. Clinical Delineation of Birth Defects of the Gastro-intestinal Tract including Liver and Pancreas. Baltimore: Williams and Wilkins 1972 Part XIII: 180-181
  • 43 Aoyagi K, Mitsuo I, Takashi Y. et al . Characteristic endoscopic features of intestinal lymphangiectasia: correlation with histological findings.  Hepatogastroenterology. 1997;  44 133-138
    Google Scholar
  • 44 Barnes RE, DeRidder PH. Fat absorption in patients with functional intestinal lymphangiectasia and lymphangiectic cysts.  Am J Gastroenterol. 1993;  88 887-890
    Google Scholar
  • 45 Salomons HA, Kramer P, Nikulasson S. et al . Endoscopic features of longstanding primary intestinal lymphangiectasia.  Gastrointestinal Endoscopy. 1995;  41 516-518
    Google Scholar
  • 46 Patel AS, DeRidder PH. Endoscopic appearance and significance of functional intestinal lymphangiectasia of the duodenal mucosa.  Gastrointest Endosc. 1990;  36 367-368
    Google Scholar
  • 47 Antao B, Bishop J, Shawis R. et al . Clinical application and diagnostic yield of wireless capsule endoscopy in children.  J Laparoendosc Adv Surg Tech A. 2007;  17 364-370
    Google Scholar
  • 48 Hubalewska- Hola A, Sowa- Staszczak A, Szczerbinski T. et al . Protein losing enteropathy detected by Tc99m-labelled serum albumin ab-dominal scintigraphy – case report.  Przegl Lek. 2003;  60 606-608
    Google Scholar
  • 49 Kuroiwa G, Takayama T, Sato Y. et al . Primary intestinal lymphangiectasia successfully treated with octreotide.  J Gastroenterology. 2001;  36 129-132
    Google Scholar
  • 50 Makhija S, von der Weid Py, Meddings J. et al . Octreotide in intestinal lymphangiectasia: lack of a clinical response and failure to alter lymphatic function in a guinea pig model.  Can J Gastroenterol. 2004;  18 681-685
    Google Scholar

Correspondence

Mr. A. P. DesaiMBBS, MS, MCh, DNB, FEBPS, FRCS 

Department of Pediatric Surgery

King's College Hospital

Denmark Hill

London

United Kingdom

SE5 9RS

Telefon: +44/79/1059 06 80

Fax: +44/20/3299 40 21

eMail: ashishdesai@doctors.org.uk

      >